Hopkinson Craig C. 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Hopkinson Craig C.（CIK 1730048）在 1 家公司共报告 39 笔 SEC Form 4 内部人交易（最近一笔 2026-09-01）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-01 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 买入 | 5,000 | $122,950 |
| 2026-09-01 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $422,874 |
| 2026-08-03 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 买入 | 104 | $2,011 |
| 2026-08-03 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 买入 | 4,896 | $120,393 |
| 2026-08-03 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $437,220 |
| 2026-07-01 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 买入 | 5,000 | $96,700 |
| 2026-07-01 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 卖出 | 8,300 | $427,129 |
| 2026-07-01 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 卖出 | 700 | $36,492 |
| 2026-06-01 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 买入 | 5,000 | $96,700 |
| 2026-06-01 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $375,030 |
| 2026-05-01 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 买入 | 5,000 | $96,700 |
| 2026-05-01 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $300,600 |
| 2026-04-01 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 买入 | 5,000 | $96,700 |
| 2026-04-01 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $319,590 |
| 2026-03-04 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 买入 | 5,000 | $96,700 |
| 2026-03-04 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 卖出 | 9,000 | $267,480 |
| 2026-02-27 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 买入 | 6,866 | $0 |
| 2026-02-27 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 卖出 | 3,049 | $93,696 |
| 2026-02-25 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 买入 | 7,689 | $0 |
| 2026-02-25 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 卖出 | 3,414 | $109,897 |
| 2026-02-20 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 买入 | 8,897 | $0 |
| 2026-02-20 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 卖出 | 3,504 | $112,198 |
| 2026-02-20 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 买入 | 7,673 | $0 |
| 2026-02-20 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 卖出 | 3,407 | $109,024 |
| 2026-02-06 | Alkermes plc. (ALKS) | EVP R&D, Chief Medical Officer | 买入 | 25,352 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-01